What is the webinar about?
Per- and polyfluorinated alkyl substances (PFAS) are a large family of artificial chemicals widely used in industry for their unique properties. Due to increasing global concerns over their effects on environment and human health, the regulatory landscape is rapidly evolving and more and more restrictions to the production and use of PFAS are being implemented.
Several leading suppliers are currently discontinuing PFAS production, and the EU is proposing a full ban on PFAS expected to hit by 2030. The phase out of these chemicals will affect many medical devices which use PFAS as constituent materials or part of the manufacturing process. In the Webinar we will provide an overview of the main challenges that medical device manufacturers are expected to face in the near future and the impact these may have on CE marking of their medical devices.
What will participants gain?
- An understanding of the timeline and steps of the restrictions to production and use of PFAS in medical devices.
- An introduction on what the next steps may be for manufacturers and how best to engage with the Notified Body.
Who should attend?
This insightful webinar will be beneficial to all BSI Medical Devices clients and manufacturers.
Register here.
